Hepion Pharmaceuticals, Inc.
(NASDAQ : HEPA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.06%167.670.7%$1125.22m
PFEPfizer Inc. -1.17%49.280.9%$917.49m
ABBVAbbVie, Inc. -0.80%141.411.9%$813.19m
LLYEli Lilly & Co. 2.24%317.251.1%$802.70m
MRKMerck & Co., Inc. 0.44%90.990.7%$796.41m
BMYBristol-Myers Squibb Co. 0.56%74.541.0%$649.52m
SIGASIGA Technologies, Inc. 1.89%24.780.0%$473.03m
AZNAstraZeneca Plc -0.44%66.451.0%$368.06m
GBTGlobal Blood Therapeutics, Inc. 0.01%67.015.6%$332.78m
GSKGSK Plc -1.62%34.690.3%$279.64m
ALNYAlnylam Pharmaceuticals, Inc. -2.26%222.998.2%$270.27m
VERUVeru, Inc. 7.03%23.820.0%$240.02m
HZNPHorizon Therapeutics Plc -3.67%61.735.4%$212.46m
KRTXKaruna Therapeutics, Inc. -1.12%260.740.0%$202.73m
CCXIChemoCentryx, Inc. -0.16%50.782.9%$202.00m

Company Profile

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. The company was founded on May 15, 2013 and is headquartered in Edison, NJ.